MD&A I just read the MD&A and I must say I'm impressed. They have a boat load of cash from that last raise, arming them for continuity for at least 12 months, so no worries there. What I absolutely love is the breakdown of exactly how they are spending, and plan to spend, their cash. That is what I call transparency. The pandemic has really slowed everything in the pharma world that isn't related to a vaccine, so I'm not concerned about delays. IMO, CBD will be found to be a quality therapeutic for Covid related inflammation, particularly in the heart muscle. This will be excellent news for Cardiol shareholders.